In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.01, marking a -8.03% move from the previous day. This change lagged the S&P 500's daily loss of 0.06%. Meanwhile, the Dow ...

Google today announced its new EmbeddingGemma 2 model that can be used to “organize, search, and connect information directly on consumer hardware.” To show off its potential, Google created an AI ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

OpenAI caught something unusual while training its latest model, GPT-5.6 Sol: It began leaving instructions for future versions of itself, telling them to conceal mistakes and misaligned behavior from ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Nice high-res matte screen. Excellent pen with good pressure sensitivity. Good handwriting conversion tools. Works well as an ebook reader. Great for watching video. Keyboard case adds unnecessary ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...